Tags

Type your tag names separated by a space and hit enter

Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases.
Asian J Androl. 2018 Sep-Oct; 20(5):438-441.AJ

Abstract

We summarized our experience in transurethral seminal vesiculoscopy (TSV) for recurrent hemospermia by introducing surgical techniques, intraoperative findings, and treatment outcomes. TSV was performed in 419 patients with an initial diagnosis of persistent hemospermia at Shanghai Changhai Hospital (Shanghai, China) from May 2007 to November 2015. TSV was successfully performed in 381 cases (90.9%). Hemospermia was alleviated or disappeared in 324 (85.0%) patients by 3 months after surgery. Common intraoperative manifestations were bleeding, obstruction or stenosis, mucosal lesions, and calculus. Endoscopic presentation of the ejaculatory duct orifice and the verumontanum was categorized into four types, including 8 (1.9%), 32 (7.6%), 341 (81.4%), and 38 (9.1%) cases in Types A, B, C, and D, respectively. TSV is an effective and safe procedure in the management of seminal tract disorders. This study may help other surgeons to become familiar with and improve this procedure. However, further multicentric clinical trials are warranted to validate these findings.

Authors+Show Affiliations

Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Medical College of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital, Beijing 100853, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

29735816

Citation

Chen, Rui, et al. "Transurethral Seminal Vesiculoscopy for Recurrent Hemospermia: Experience From 419 Cases." Asian Journal of Andrology, vol. 20, no. 5, 2018, pp. 438-441.
Chen R, Wang L, Sheng X, et al. Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases. Asian J Androl. 2018;20(5):438-441.
Chen, R., Wang, L., Sheng, X., Piao, S. G., Nian, X. W., Cheng, X., Zhou, T., Li, H. Z., Liu, Y. W., Chen, G. H., Zhang, C. L., Kong, D. P., Xiao, G. A., Lu, X., Jia, Z. Y., Liu, Z. Y., & Sun, Y. H. (2018). Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases. Asian Journal of Andrology, 20(5), 438-441. https://doi.org/10.4103/aja.aja_76_17
Chen R, et al. Transurethral Seminal Vesiculoscopy for Recurrent Hemospermia: Experience From 419 Cases. Asian J Androl. 2018 Sep-Oct;20(5):438-441. PubMed PMID: 29735816.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases. AU - Chen,Rui, AU - Wang,Lei, AU - Sheng,Xia, AU - Piao,Shu-Guang, AU - Nian,Xin-Wen, AU - Cheng,Xin, AU - Zhou,Tie, AU - Li,Hui-Zhen, AU - Liu,Ya-Wei, AU - Chen,Guang-Hua, AU - Zhang,Chun-Lei, AU - Kong,De-Pei, AU - Xiao,Guang-An, AU - Lu,Xin, AU - Jia,Zhen-Yu, AU - Liu,Zhi-Yong, AU - Sun,Ying-Hao, PY - 2018/5/8/pubmed PY - 2019/9/7/medline PY - 2018/5/9/entrez KW - endoscopy KW - hemospermia KW - transurethral seminal vesiculoscopy SP - 438 EP - 441 JF - Asian journal of andrology JO - Asian J Androl VL - 20 IS - 5 N2 - We summarized our experience in transurethral seminal vesiculoscopy (TSV) for recurrent hemospermia by introducing surgical techniques, intraoperative findings, and treatment outcomes. TSV was performed in 419 patients with an initial diagnosis of persistent hemospermia at Shanghai Changhai Hospital (Shanghai, China) from May 2007 to November 2015. TSV was successfully performed in 381 cases (90.9%). Hemospermia was alleviated or disappeared in 324 (85.0%) patients by 3 months after surgery. Common intraoperative manifestations were bleeding, obstruction or stenosis, mucosal lesions, and calculus. Endoscopic presentation of the ejaculatory duct orifice and the verumontanum was categorized into four types, including 8 (1.9%), 32 (7.6%), 341 (81.4%), and 38 (9.1%) cases in Types A, B, C, and D, respectively. TSV is an effective and safe procedure in the management of seminal tract disorders. This study may help other surgeons to become familiar with and improve this procedure. However, further multicentric clinical trials are warranted to validate these findings. SN - 1745-7262 UR - https://www.unboundmedicine.com/medline/citation/29735816/Transurethral_seminal_vesiculoscopy_for_recurrent_hemospermia:_experience_from_419_cases_ L2 - http://www.ajandrology.com/article.asp?issn=1008-682X;year=2018;volume=20;issue=5;spage=438;epage=441;aulast=Chen DB - PRIME DP - Unbound Medicine ER -